Study of Aarogyavardhini Vati and Navak Guggulu with Triphala Kwath in Obesity.

To Study the Effect of Aarogyavardhini Vati and Triphala Kwath Against Navak Guggulu and Triphala Kwath in Sthaulya with special reference to Obesity: Randomized control Study.

Status

Recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/01/048772

Enrollment

Registered

2023-01-05

Start date

Unknown

Completion date

Unknown

Last updated

2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E669- Obesity, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients having clinical features of Sthaulya ( >50%) according to classics. 2.Patients of Sthaulya having BMI more than 25Kg/m2 and less than 40Kg/m2. 3.Patients of either sex of age between 18- 60 years are included. 4.Those patients of Sthaulya who are willing to participate in study and ready to give written consent will be included. 5.Patient who had not participated in any research work since last six months will be included.

Exclusion criteria

Exclusion criteria: 1.Patients of Sthaulya having BMI less than 25Kg/m2 and more than 40Kg/m2 will be excluded. 2.Patients having age below 18yrs and above 60yrs will be excluded. 3.Patients of Obesity due to hypothyroidism and Obesity with having clinical history of any other systemic disorders like Ischemic heart disease Patients with complicated and chronic disorder like Nephrotic syndrome, Jaundice, Hepatitis, chronic infections and other serious diseases will be excluded. 4.Patients of Sthaulya with uncontrolled hypertension (systolic BP >140mmHg and diastolic BP >100mmHg) and uncontrolled diabetes (Fasting >130mg/dl and Post meal >200mg/dl) mellitus will be excluded. 5.Patients of drug induced Obesity for example Hormonal replacement therapy, consumption of anabolic steroids etc. and any drugs that may influence on the outcome of the study will be excluded. 6.Pregnant females & lactating mothers will be excluded. 7.Patients who are currently participating in other clinical trials (since last six months) will be excluded. 8.Patient with evidence of malignancy.

Design outcomes

Primary

Measure	Time frame
To evaluate the efficacy of Aarogyavardhini Vati and Triphala Kwath in Sthaulya w.s.r. to Obesity on symptoms of Sthaulya during period of 30 days.Timepoint: 30 days	—

Secondary

Measure	Time frame
1.To compare the efficacy of Aarogyavardhini Vati and Triphala Kwath with Navak Guggulu and Triphala Kwath in Sthaulya wsrt Obesity. 2.To evaluate the efficacy of Aarogyavardhini Vati and Triphala Kwath in Sthaulya w.s.r. to Obesity on BMI and circumference of waist and hip. 3.To study the literature of Sthaulya as per Ayurvedic perspective. 4.To study the literature of Obesity as per modern texts. Timepoint: 30 Days	—

Measure

Time frame

1.To compare the efficacy of Aarogyavardhini Vati and Triphala Kwath with Navak Guggulu and Triphala Kwath in Sthaulya wsrt Obesity. 2.To evaluate the efficacy of Aarogyavardhini Vati and Triphala Kwath in Sthaulya w.s.r. to Obesity on BMI and circumference of waist and hip. 3.To study the literature of Sthaulya as per Ayurvedic perspective. 4.To study the literature of Obesity as per modern texts. Timepoint: 30 Days

—

Countries

India

Contacts

Public ContactMohini Hanumant Jamale

Government Ayurved College,Nagpur

jayant.gulhane.62.6@gmail.com9822922399

Outcome results